Company Stock Price of Albemarle Corporation (ALB) Increases 3.07%

Albemarle Corporation stock performance trend indicates that the stock price has rallied 19.58% in the past 12 Weeks , but analyzing the 6 month charts for the stock , the price continues to stay positive and keep the rally at 24.24% . Looking at the past 52 week period, the stock price is up at 73.04% . Relative price strength is a important factor used by wealth management firms while investing in stocks because the indicator compares the stock performance with the overall market. The relative price strength of Albemarle Corporation has a positive value of 40.02 compared to overall market.Albemarle Corporation is having a Relative Strength Index of 68.2 which indicates the stock is not yet over sold or over bought based on the technical indicators.

Albemarle Corporation (NYSE:ALB) has climbed 3.07% in the past week and advanced 15.55% in the last 4 weeks. In the past week, the company has outperformed the S&P 500 by 2.82% and the outperformance has advanced to 14.23% for the last 4 weeks period.

For the current week, the company shares have a recommendation consensus of Buy. Albemarle Corporation (NYSE:ALB) : On Friday heightened volatility was witnessed in Albemarle Corporation (NYSE:ALB) which led to swings in the share price. The stock opened for trading at $104.49 and hit $106.53 on the upside , eventually ending the session at $106.21, with a gain of 2.12% or 2.2 points. The heightened volatility saw the trading volume jump to 1,436,880 shares. The 52-week high of the share price is $106.53 and the company has a market cap of $11,956 million. The 52-week low of the share price is at $60.34 .

Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.Company shares were Reiterated by RBC Capital Mkts on Mar 17, 2017 to Outperform, Raises Price Target to $ 132 from a previous price target of $130 .Albemarle Corporation was Downgraded by Citigroup to Neutral on Mar 6, 2017. Company shares were Reiterated by RBC Capital Mkts on Mar 1, 2017 to Outperform, Raises Price Target to $ 130 from a previous price target of $114 .Albemarle Corporation was Initiated by RBC Capital Mkts on Feb 23, 2017 to Outperform, Price Target of the shares are set at $114.Company shares were Upgraded by Robert W. Baird on Jan 17, 2017 to Outperform, Raises Price Target to $ 118 from a previous price target of $81 .

Company has reported several Insider transactions to the SEC, on Mar 6, 2017, Scott Tozier (EVP & CFO) sold 2,783 shares at 103.77 per share price.On Mar 6, 2017, Karen G Narwold (EVP, Chief Admin Officer) sold 945 shares at 103.43 per share price.On Mar 6, 2017, Luther C Iv Kissam (Chairman, President & CEO) sold 4,929 shares at 103.60 per share price.

Albemarle Corporation Last issued its quarterly earnings results on Feb 27, 2017. The company reported $0.78 EPS for the quarter, beating the analyst consensus estimate by $ 0.05. Analyst had a consensus of $0.73. The company had revenue of $696.70 million for the quarter, compared to analysts expectations of $647.56 million. The companys revenue was down -3.6 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $1.03 EPS.

Albemarle Corporation is a major producer of fine and performance chemicals including polymer intermediates, cleaning product intermediates and additives, agricultural chemical intermediates, pharmaceutical intermediates, catalysts, brominated flame retardants, bromine chemicals and potassium and chlorine chemicals.

Albemarle

Leave a Reply

Your email address will not be published. Required fields are marked *